NTRBW
Price:
$1.9
Market Cap:
$43.21M
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.[Read more]
Industry
Biotechnology
IPO Date
2021-10-01
Stock Exchange
NASDAQ
Ticker
NTRBW
According to Nutriband Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.76. This represents a change of -48.79% compared to the average of -7.34 of the last 4 quarters.
The mean historical PE Ratio of Nutriband Inc. over the last ten years is -9565.79. The current -3.76 PE Ratio has changed -96.07% with respect to the historical average. Over the past ten years (40 quarters), NTRBW's PE Ratio was at its highest in in the July 2015 quarter at 0. The PE Ratio was at its lowest in in the January 2016 quarter at -21428.31.
Average
-9565.79
Median
-31.13
Minimum
-85713.25
Maximum
-3.53
Discovering the peaks and valleys of Nutriband Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 157.42%
Maximum Annual PE Ratio = -3.53
Minimum Annual Increase = -99.74%
Minimum Annual PE Ratio = -85713.25
Year | PE Ratio | Change |
---|---|---|
2024 | -3.78 | -41.03% |
2023 | -6.42 | 81.72% |
2022 | -3.53 | -89.08% |
2021 | -32.34 | 3.90% |
2020 | -31.13 | -42.34% |
2019 | -53.99 | 157.42% |
2018 | -20.97 | -90.75% |
2017 | -226.66 | -99.74% |
The current PE Ratio of Nutriband Inc. (NTRBW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.58
5-year avg
-15.44
10-year avg
-9565.79
Nutriband Inc.’s PE Ratio is greater than Nutriband Inc. (-6.31), less than HCW Biologics Inc. (-0.40), less than NRx Pharmaceuticals, Inc. (-0.85), less than Biofrontera Inc. (-0.45), greater than ZIVO Bioscience, Inc. (-5.50),
Company | PE Ratio | Market cap |
---|---|---|
-6.31 | $43.21M | |
-0.40 | $15.05M | |
-0.85 | $18.95M | |
-0.45 | $7.58M | |
-5.50 | $78.37M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nutriband Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nutriband Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nutriband Inc.'s PE Ratio?
How is the PE Ratio calculated for Nutriband Inc. (NTRBW)?
What is the highest PE Ratio for Nutriband Inc. (NTRBW)?
What is the 3-year average PE Ratio for Nutriband Inc. (NTRBW)?
What is the 5-year average PE Ratio for Nutriband Inc. (NTRBW)?
How does the current PE Ratio for Nutriband Inc. (NTRBW) compare to its historical average?